Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed- dose ophthalmic solution: A randomized, comparative, controlled study in healthy volunteers

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 3, 1999, Pages 203-208

  Salvá, Pau ^a,c   Costa, J ^a   Andreu, D ^a   Notivol, R ^b   Martinez M ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Clinical Center   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Diclofenac; Ophthalmic solution; Tobramycin; Tolerability

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DICLOFENAC; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT; TOBRAMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; EYE DISEASE; EYE INFLAMMATION; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0033056058     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.3.534830     Document Type: Article

References (28)

1. Leibowitz, H.M., Kupferman, A. Drug interaction in the eye. Concurrent corticosteroid-antibiotic therapy far inflammatory keratitis. Arch Ophthalmol 1977, 95: 682-5.
2. Schoenwald, R.D., Harris, R.G., Turner, D., Knowles, W., Chien, D-S. Ophthalmic bioequivalence of steroid/antibiotic combination formulations. Biopharmceut Drug Disposition 1985, 8: 527-48.
3. Leibowitz, H.M., Pratt, M.V., Flagstad, I.J., Berrospi, A.R., Kundsin, R. Human conjunctivitis. II. Treatment. Arch Ophthalmol 1976, 94: 1752-6.
4. Gwon, A. Ofloxacin vs tobramycin for the treatment of external ocular infections. Arch Ophthalmol 1992, 110: 1324-37.
5. Kraff, M.C., Martin, R.G., Neumann, A.C., Weinstein, A.J. Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg 1994, 20: 138-44.
6. Voltaren Ophthalmic. Approval letter, package insert, medical officers review, pharmacology, toxicology review, chemistry review and microbiology review. Documentation by Food and Drug Administration. July 1993.
7. Stodtmeister, R., Marquardt, R. Ein nichtsteroidaler entzündungshemmer bei chronischer conjunctivitis. Fortschr Ophthalmol 1986, 83: 199-202.
8. Ilic, J., Gigon, S., Leuenberger, P.M. Comparaison de l'effet antiinflammatoire des collyres de dexamethasone et de diclofenac. Klin MBL Augenheilk 1984, 184: 494-8.
9. Stewart, R.H., Kimbrough, R.L., Smith, J.P., DeFaller, J.M. Use of steroid/antibiotic prophylaxis in intraocular lens implantation: A double-masked study vs placebo. Ann Ophthalmol 1983, 15: 24-8.
10. Othenin-Girard, P.H., Tritten, J-J., Pittet, N., Herbort, C.P. Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. J Cataract Refract Surg 1994, 20: 9-11.
11. Flach, A.J. Cyclo-oxygenase inhibitors in ophthalmology. Mindel, J., Mishima, S. (Eds.). Surv Ophthalmol 1992, 36: 259-84.
12. Igual, A., Rebollo, L., Riu, J.L., Heaton, J., Hackett, R.B., Tortajada, A., Canut, L., Guasch, J., Bergamini, M.V.W. Preclinical ocular toxicity of 0.1% diclofenac sodium-0.3% tobramycin (DT) eyedrops. Ophthal Res 1997, 29: 51.
13. Tirado, M., Vidal, R., Guasch, J., Bergamini, M.V.W. In vitro and in vivo efficacy of 0.1 % diclofenac sodium-0.3% tobramycin eyedrops (DT). Ophthal Res 1997, 29: 51.
14. Vidal, R., Riu, J.L., Martíez, C., Costa, J., López, S., Vilageliu, J., Guasch, J., Bergamini, M.V.W. 0.1% Diclofenac sodium-0.3% tobramycin eyedrops (DT): Efficacy and ocular distribution of diclofenac and tobramycin. Methods Find Exp Clin Pharmacol 1997, 19(Suppl A): 191.
15. Scoville, B., Krieglstein, G.K., Then, E., Yokoyama, S., Yokoyama, T. Measuring drug induced eye irritation: A simple new clinical assay. J Clin Pharmacol 1985, 25: 210-8.
16. Torrent, J., Gich, I., Barbanoj, M.J., Conte, A., Aguilar, J.A., Jane, F. Objective and subjective assessment of eye irritation induced by antiinflammatory agents in healthy volunteers. Cur Ther Res 1990, 47: 1021-36.
17. Badian, M., Dabrowski, J., Grigoleit, H.G. et al. Decrease of intraocular pressure (IOP) by forskolin (F) in healthy subjects. Gillespie, J.S. (Ed.). Proc IUPHAR 9th Int Cong Pharmacol McMillan Press Ltd: London 1984, 1314.
18. Draize, J.H., Woodard, G., Calvery, H.O. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944, 82: 377-90.
19. Kriegistein, G.K., Scoville, B. Eye irritation caused by topical beta-blocker therapy. A new methodological screening approach. In: Second European Glaucoma Symposium. Greve, E.L., Leydhecker, W., Raitta, C. (Eds.). Dr. W. Junk Publishers: Dordretch 1984, 21-6.
20. Hugues, F.C., Le Jeunne, C. Systemic and local tolerability of ophthalmic drugs formulations. Drug Safety 1993, 8: 365-80.
21. Basu, P.K. Toxic effects of drugs on the corneal epithelium: a review. J Toxicol-Cutaneous Ocular Toxicol 1983-4, 2: 205-77.
22. George, J.L. Les altérations cornéennes conjonctivales et lacrymales. In: Les Effects Indésirables des Médicaments en Ophthalmologie. Raspiller et al. (Eds.) Bulletin des Societés d'Ophthalmologie de France, rapport annuel. Masson: Paris, 1985.
23. Lebuisson, D.A., Aron, J.J., Coudert, J.L. Les accidents des médicaments ophthalmologiques. Revue du Practicien 1982, 32: 57-63.
24. Riedl, B., Reitmeier, G., Heese, A., Hahn, H., Peters, K.P., et al. Type IV allergies to components of ophthalmology. Klinische Monatsblauer für Augenheilkunde 1991, 198: 251-4.
25. Vadot, E., Piasentin, D. Fréquence des allergies de contact aux collyres en milieu hospitalier: Résultats d'une étude prospective. J Français d'Ophthalmologie 1986, 9: 41-3.
26. Pichon, P., Moreau, G. Complications cornéennes par usage de collyre a l'indométacine. Bulletin des Societés d'Ophthalmologie de France 1990, 90: 449-51.
27. Burns, C. Indomethacin reduced corneal sensitivity, and corneal deposits. Am J Ophthalmol 1968, 66: 825-35.
28. Nehme, S., Trouve, O., Renard, G. La gentamycine en ophthalmologie: spectre, indications, voies d'administration, toxicité et tolérance. J Français d'Ophthalmologie 1980, 10: 595-605.